

























































z Medicinal Chemistry & Drug Discovery
Microwave-Assisted Synthesis of Some Hybrid Molecules
Derived from Morpholine and Investigation of Their
Antimicrobial Activities
Yıldız Uygun Cebeci,[a] Serap Basoglu Ozdemir,[a] Sule Ceylan,[b] Hacer Bayrak,[c]
Ahmet Demirbas,[a] Sengul Alpay-Karaoglu,[d] and Neslihan Demirbas*[a]
2H-1,2,4-triazol-3(4H)-one compound was obtained starting
from 4-(2-fluoro-4-nitrophenyl)morpholine via several steps.
Then, these compounds were converted to the corresponding
fluoroquinolone hybrids via one pot three component Mannich
reaction. Moreover, the synthesis of eleven compounds, which
can be considered as conazole analogues, was performed
starting from 1,2,4-triazole-3-one compounds via three steps by
either conventional or microwave mediated conditions. The
effect of different solvents and microwave power on microwave
prompted reactions was examined as well.
The synthesized compounds were screened for their antimicro-
bial activities, and some of them were found to possess good
to moderate activity.
Introduction
In the last two decades, fungal infections have become a
continuous and serious threat to human health and life.
Infections caused by fungi, which are the heterotrophic
eukaryotic organisms using almost any surface for their growth
are classified into three groups incorporating (1) allergic
reactions to fungal proteins (2), toxic reactions to toxins present
in certain fungi and (3) infections(mycoses). Many fungal
infections are caused by opportunistic pathogens that may be
endogenous (Candida infections) or acquired from the environ-
ment (Cryptococcus, Aspergillus infections). Invasive fungal
infections and dermatomycoses produced by fungal organisms
constitute the other type of fungal infections mostly emerging
in the individuals with increased vulnerability such as neonates,
cancer patients receiving chemotherapy, organ transplant
patients, and burns patients, apart from those with acquired
immune deficiency syndrome (AIDS). Other risk factors include
the long term use of corticosteroid and antibiotics, diabetes,
lesions of epidermis and dermis, malnutrition, neutropenia and
surgery.[1–7]
Beside fungal infections, certain bacterial diseases have
become potential threat to human health and these bacterial
diseases yet have not been overcome. Literature survey
revealed that, more than one-third of the world populations
are infected by bacterial pathogens and nearly two million
people per year die due to these infections.[8] The overuse and
misuse of common antibiotics has resulted in resistance in
certain bacteria and the human pathogen no longer response
to these clinically used antibiotics, although significant progress
has been made for the treatment and control of microbial
infections by introducing new strategies and combinatorial
therapy. The alarming rates of emerging and reemerging
microbial threats coupled with increasing antibacterial resist-
ance have emphasized the urgent need for new and more
effective antibacterial agents with high safety profile.[9–14]
Among the nitrogen containing heterocyclic compounds,
N-functionalizedmorpholines apparently have gained consider-
able importance owing to their varied biological properties
including antidiabetic,[15] antiemetic,[16] platelet aggregation
inhibitors, antihyperlipoproteinemics[15] bronchodilators,
growth stimulants[17] and antidepressants.[18] These were also
used in the treatment of inflammatory diseases, pain, migraine
and asthma.[19] Recently, some morpholine derivatives possess-
ing antimicrobial activity have been synthesized in our
laboratory.[20,21]
Other N-containing heterocycle, triazole constitutes another
important bioactive nucleus in the field of medicinal
chemistry[22–26] the therapeutic effects of 1,2,4-triazole and
containing compounds have been well studied for a number of
pathological conditions including inflammation, cancer, pain,
tuberculosis or hypertension.[27–30] Ribavirin, rizatriptan, alprazo-
lam, vorozole, letrozole, and anastrozole are the best examples
of drugs containing 1,2,4-triazole moiety.[31–33] Among azole-
based drugs, conazoles, such as itraconazole, fluconazole,
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voriconazole, posaconazole and ravuconazole constitute a
major class being used for the treatment of fungal infections[34–
36] (figure 1).
Fluoroquinolone antibacterial agents constitute a fastgrow-
ing group of antibiotics; various derivatives were synthesized
and tested for their antimicrobial activities. The new gener-
ations of fluoroquinolones achieved significant improvement in
potency, spectrum and physicochemical properties.[37] Several
compounds with broad spectrum antibacterial activity have
been introduced by the N-4 substitution of piperazin on
fluoroquinolones,[38,39] some of which have been studied in our
laboratory.[30] Also, isatineMannich bases of gatifloxacin, a
floroquinolone class antibacterial have been obtained as potent
anticancer agents.[40]
In recent years, to overcome the drug resistance problem,
the concept of hybrid molecules, which contain two or more
pharmacophore groups binding together covalently in one
molecular framework, has been introduced in the medicinal
chemistry field. Themodification of structural units in the
existing drugs or the synthesis of their novel analogues has
become one of most promising and applied strategy aiming to
overcome drug resistance. Some reasons, such as not including
the discovery of new scaffolds or validation of novel biological
targets, which require difficult and time-consuming work, have
made this procedure attractive.[41–43] It has been reported that
the compounds obtained by molecular hybridization of several
pharmacophore groups act by inhibiting two or more conven-
tional targets simultaneously, and this multiple target strategy
has resulted in the development of a number of bioactive
hybrid molecules.[44]
Microwave-assisted organic synthesis has also received
great attention due to some advantages including reduction of
reaction times, minimization of by-products and increased
yields. So the application of microwaves has become a
particularly attractive way for the preparation of key intermedi-
ates and new bioactive molecules.[15,30]
In this study focused on the design, eco friendly synthesis
and antimicrobial evaluation of new azole class antifungals.
Moreover, the synthesis of morpholine-azole-fluoroquino-
lone hybrids were intended as well, based on pharmacophores
hybridization. Morpholine scaffold was selected as the key
prototype structural unit and the integration of morpholine
skeleton, azole and fluoroquinolonepharmacophoreswith differ-
ent mode of action in the one molecular frame was performed
as shown in figure 3 with the aim to prepare new antibacterial




The synthetic strategies adopted to obtain the target com-
pounds are depicted in Schemes 1 and 2, and the substituents
on compounds 2–6 were presented in table 1. In the present
study, the synthesis of compound 1 was performed following
the procedure reported by us earlier.[45] Compounds3a and 3 b
were synthesized starting from compound 1 via two steps by
conventional and microwave irradiated techniques. This idea
originated from the aim to obtain an active hydrogen
compound with biological activity that can be used as an
intermediate for further condensation reactions leading to the
formation of new bioactive products. Moreover, this hetero-
cycle which constitutes one of active part of azole class
antifungal is necessary for the construction of new conazole
analogues targeted in the present study. In order to optimize
the method, microwave (MW) irradiation was applied at differ-
ent power values of 100, 150 and 200 W and the progress of
reaction was monitored by TLC. The complete conversion of
the starting carboxamide (2 a, 2 b) was observed after micro-
Figure 1. Some known azole class antifungals.
Figure 2. The schematic representation of the relationship between the
structures of miconazole and the synthesized conazole analogues.
Figure 3. General representation of the target compounds
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wave irradiation at 150 W for 15 min. It is noteworthy to
underline that shorter reaction time or lower microwave energy
power caused to lower conversion rate, while increasing
reaction time or MW power resulted in decomposition of the
target product as revealed by TLC analysis.
Compared to the classical method, microwave mediated
method supplied an alternative route with much shorter
reaction duration and better yield for the synthesis of
compounds 3 a and 3 b. These compounds (3 a, 3 b) were
characterized by the presence of NH band at 3286 or
3289 cm1 in the FT-IR spectra. This proton was resonated
between 8.66-8.99 ppm in the 1H NMR spectra as D2O ex-
changeable singlet. Moreover these compounds displayed
elemental analysis results confirming the proposed structures.
The treatment of 1,2,4-triazole-3-one (3 a,b) with 2-bromo-
1-(4-chlorophenyl)ethanone (for4a, 4 b) or 2-chloro-1-(2,4-di-
chlorophenyl)ethanone (for 4 c, 4 d) produced compounds 4 a–
d. Two methods including conventional heating under reflux
conditions (Method 1) and MW irradiated method (Method 2)
were used for the preparation of 4 a–d. The obtained results
revealed that the latter technique supplied more useful
procedure with much shorter reaction duration of 15 min. while
conventional method requires 6 hours. In the method 2, higher
temperatures than 150 8C or higher microwave energy than
175 W resulted in a decrease in yields of compounds 4 a–d or
completely decomposition.
The support for the formation of the targeted compounds,
4 a–d is the appearance of [M + H], [M + H2O], [M + K + 2H]ion
peaks at corresponding m/z values confirming their molecular
masses; and these compounds gave elemental analysis results
consistent with the proposed structures. The reduction of
exocyclic carbonyl function of compounds 4 a–d to alcohol was
achieved in the presence of NaBH4 in ethanol using both
conventional and MW irradiated methods. For MW mediated
reactions leading to the formation of compounds 5 a–d, the
production of compound 5 b was selected as model and the
effects of various reaction parameters, including solvent,
temperature, time and MW power were examined on the
model reaction, and the results are summarized in (Table 2).
The obtained results showed that the MW irradiation
supplied more suitable method with shorter reaction time and
improved yields. The FT-IR and 1H NMR spectra of these
compounds displayed signal originated from -OH proton
(exchangeable with D2O) between 4.02–5.28 ppm, while no
signal due to carbonyl function was present in the FT-IR
spectra. In addition, compounds 5 a–d gave Mass spectral data
and elemental analysis consistent with the assigned structures.
The synthesis of compounds 6 a–k, which were regarded as
new analogs of azole class antifungals was achieved by
treatment of compounds 5 a–d with chlorinated benzyl
chlorides, namely 4-chloro-, 2,4-dichloro- and 2,6-dichloroben-
zyl chlorides in the presence of NaH under MW-mediated and
conventional conditions. In order to improve the MW con-
ditions, the reaction leading to the formation of 6 b was
selected as a model reaction and the effects of several
parameters including time, power and solvent were examined.
The best conditions were obtained with 10 minutes of MW
Scheme 1. Reaction and conditions: i: DCM, benzylisocyanate (for 2 a) or
phenylisocyanate (for 2 b), rtor 80 W MW; ii: NaOH, EtOH-H2O, reflux or 150 W
MW; iii: 2-bromo-1-(4-chlorophenyl)ethanone or 2-chloro-1-(2,4-dichloro-
phenyl)ethanone, NaOEt, reflux or 175 W MW; iv: NaBH4, EtOH, reflux; v: 2,6-
dichlorobenzylchloride, 2,4-dichlorobenzylchloride or 4-chlorobenzylchloride,
THF, NaH, reflux or 200 W MW.
Scheme 2. i: Ciprofloxacine or norfloxacine, DMF, HCHO, rt or 50 W MW.
Table 1. Substituents on compounds 2–6.
Comp. No. R Ar Ar’
2a -CH2C6H5 - -
2b -C6H5 - -
3a -CH2C6H5 - -
3b -C6H5 - -
4a -CH2C6H5 -C6H4Cl(-4) -
4b -C6H5 -C6H4Cl(-4) -
4c -CH2C6H5 -C6H3Cl2(-2,4) -
4d -C6H5 -C6H4Cl(-2,4) -
5a -CH2C6H5 -C6H4Cl(-4) -
5b -C6H5 -C6H4Cl(-4) -
5c -CH2C6H5 -C6H3Cl2(-2,4) -
5d -C6H5 -C6H4Cl(-2,4) -
6a -CH2C6H5 -C6H4Cl(-4) -C6H4Cl(-4)
6b -C6H5 -C6H4Cl(-4) -C6H4Cl(-4)
6c -CH2C6H5 -C6H4Cl(-4) -C6H3Cl2(-2,4)
6d -C6H5 -C6H4Cl(-4) -C6H3Cl2(-2,4)
6e -CH2C6H5 -C6H4Cl(-4) -C6H3Cl2(-2,6)
6f -C6H5 -C6H3Cl2(-2,4) -C6H4Cl(-4)
6 g -CH2C6H5 -C6H3Cl2(-2,4) -C6H4Cl(-4)
6 h -C6H5 -C6H3Cl2(-2,4) -C6H3Cl2(-2,4)
6j -CH2C6H5 -C6H3Cl2(-2,4) -C6H3Cl2(-2,4)
6k -C6H5 -C6H3Cl2(-2,4) -C6H3Cl2(-2,6)
6 l -CH2C6H5 -C6H3Cl2(-2,4) -C6H3Cl2(-2,6)
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irradiation at 200 W in MeCN. After optimization of the
conditions for the preparation of 6 b, the synthesis of the
remaining compounds 6 was carried out. Comparison of two
methods, conventional and MW irradiated procedures showed
that with the use of MW irradiation provided more efficient and
green way for the synthesis of compounds 6 a–k with the
better reaction yields and much shorter reaction times. In the
NMR spectra of compounds 6 a–k, the number of signals and
their chemical shifts are in accordance with the assigned
structures. In the 1H NMR and 13C NMR spectra, additional
signals corresponding to the substituted (di)chlorobenzyloxy
group were recorded at the related chemical shift values while
1H NMR spectra of these compounds showed the disappear-
ance of the characteristic band of -OH function. Moreover, the
preparation of conazole analogs was verified by registration of
their mass spectra which were in accordance with their
molecular masses and the elemental analysis data (carbon,
hydrogen and nitrogen) were 0.4% of the theoretical values.
Compounds 3 a and 3 b were subjected to a Mannich
reaction with norfloxacine and ciprofloxacine in the presence of
formaldehyde solution under conventional and also MW
irradiated conditions. The method with MW irradiation pro-
vided more useful way with improved reaction yields and
shorter reaction times. This idea originated from the intend to
introduce the fluorophenylenmorpholine nucleus to fluoroqui-
nolone skeleton with the aim to obtain antimicrobial agents
with improved properties including broader spectrum, less
tendency to resistance, less toxic side effects etc. No signal
representing the existence of NH group is present in the FT-IR
and 1H NMR spectra of compounds 7 a–d, while the splitting
patterns of remaining protons of spectra were as expected,
according to the structures. The13C NMR spectra were also as
expected. Moreover, [M + Na], [M + 1], [M + K] or [M + H2O]ion
peaks were observed at the related m/z values supporting the
proposed structures of compounds 7 a–d (Scheme 2). In
addition, these compounds gave reasonable elemental analysis
data.
Antimicrobial activity
Most of the compounds synthesized in the present study
exhibited activity on the test compounds (table 3, only positive
results were presented). Among them, 7 a–d, which contain a
fluoroquinolone nucleus in their structures, demonstrated
excellent activities on Gram positive and Gram negative












1 18 200 97 175 EtOH
2 14 175 98 150 EtOH
3 20 150 96 125 EtOH
4 16 125 97 100 EtOH
5 10 100 90 100 EtOH
6 10 100 92 125 EtOH
Comp 5b
1 6 200 97 150 EtOH
2 8 150 99 150 EtOH
3 10 200 93 150 THF
4 4 150 96 100 THF
5 10 200 74 150 MeCN
6 10 200 81 200 MeCN
Comp 6b
1 25 100 65 100 EtOH
2 25 100 53 100 THF
3 25 100 60 100 MeCN
4 27 100 50 100 DCM
5 15 150 71 100 EtOH
6 17 150 77 100 THF
7 16 150 69 100 MeCN
8 18 150 68 100 DCM
9 10 200 65 100 EtOH
10 10 200 70 100 THF
11 10 200 73 100 MeCN
12 8 200 40 100 DCM
Table 3. Screening for the activity of newly synthesized compounds
Comp
No
Microorganismsand Minimal InhibitoryConcentrations (mg/mL)
Ec Yp Pa Sa Ef Bc Ms Ca Sc
2a - - - 250 - - 31.25 - -
2b - - - - - - - - -
3a - - - - - - - - -
3b - - - - - - - - -
4a 0.24 - - - - - - 125 125
4b - - - - - - - - -
4c 0.24 - - - - - - 125 125
4d <0.24 <0.24 <0.24 <0.24 <0.24 <0.24 - 500 -
5a 0.24 - - - - - - 125 125
5b - - - - - - - - -
5c 0.24 - - - - - - 125 125
7a <0.24 <0.24 <0.24 <0.24 <0.24 <0.24 - 125 500
7b <0.24 <0.24 <0.24 <0.24 <0.24 <0.24 - - -
7c <0.24 <0.24 <0.24 <0.24 <0.24 <0.24 - 125 -
7d <0.24 <0.24 <0.24 <0.24 <0.24 <0.24 - 500 -
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bacteria of the test microorganisms with the mic values
<0.24 mg/mL. The carboamides, 2 a, 2 b, and triazoles, 3 a, 3 b,
which were obtained from intramolecular cyclisation of 2 a, 2 b,
displayed selective activity on a Gram positive coccal bacte-
rium, Staphylococcus aureus (Sa), and Mycobacterium smegmatis
(Ms), atipical tuberculosis factor leading to morbidity and
mortality. A remarkable antifungal activity was observed for
4 a–d and 7 a–d with the MIC values varying between 8–
31.2 mg/mL.
Ec: Escherichia coli ATCC 25922, Yp: Yersinia pseudotubercu-
losisATCC 911, Pa: Pseudomonas aeruginosaATCC 43288, Sa:
Staphylococcus aureus ATCC 25923, Ef: Enterococcus faecalis
ATCC 29212, Bc: Bacillus cereus 702 Roma, Ms: Mycobacterium
smegmatis ATCC607, Ca: Candida albicans ATCC 60193, Saccha-
romyces cerevisiae RSKK 251, Amp.: Ampicillin, Str.: Streptomy-
cin (—): Flu.: Fluconazole, (—): no activity.
Antimicrobial Activity Assessment
The test microorganisms were obtained from the Hifzissihha
Institute of RefikSaydam (Ankara, Turkey) and were as follows:
Escherichia coli (E. coli) ATCC35218, Yersinia pseudotuberculosis
(Y. pseudotuberculosis) ATCC911, Pseudomonas aeruginosa (P.aer-
uginosa) ATCC43288, Enterococcus faecalis(E. faecalis)
ATCC29212, Staphylococcus aureus(S. aureus)ATCC25923, Bacil-
lus cereus (B. cereus) 709 Roma, Mycobacterium smegmatis (M.
smegmatis) ATCC607, Candida albicans(C. albicans)ATCC60193
and Saccharomyces cerevisiae (S. cerevisia) RSKK 251. All the
newly synthesized compounds were weighed and dissolved in
hexane to prepare extract stock solution of 20.000 microgram/
milliliter (mg/mL).
The antimicrobial effects of the substances were tested
quantitatively in respective broth media by using double
microdilution and the minimal inhibition concentration (MIC)
values (mg/mL) were determined. The antibacterial and anti-
fungal assays were performed in Mueller-Hinton broth (MH)
(Difco, Detroit, MI) at pH.7.3 and buffered Yeast Nitrogen Base
(Difco, Detroit, MI) at pH 7.0, respectively. The micro dilution
test plates were incubated for 18–24 h at 35 8C. Brain Heart
Infusion broth (BHI) (Difco, Detriot, MI) was used for M.
smegmatis, and incubated for 48–72 h at 35 8C [46]. Ampicillin
(10 mg) and fluconazole (5mg) were used as standard
antibacterial and antifungal drugs, respectively. Dimethyl
sulfoxide with dilution of 1:10 was used as solvent control. The
results obtained were presented in table 3.
CONCLUSION
This study reports the successful synthesis of some new hybrid
compounds starting from 4-(2-fluoro-4-nitrophenyl)morpholine.
Two methods have been used to synthesize these new
compounds: conventional and microwave. Microwave synthesis
was a more effective way of synthesizing the targeted
compounds.Moreover, the effect of acid catalyst on Mannich
reactions was investigated. The antimicrobial activity screening
studies were also performed in the study. The antimicrobial
screening suggests that the compounds containing norfloxacin
or ciprofloxacin nucleus displayed excellent antimicrobial
activity.The experimental data of the synthesized compounds
can be seen in the supporting information part.
Supporting Information Summary:
The experimental section is provided in the supporting
information.
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